325 related articles for article (PubMed ID: 30712809)
1. Neurotrophic and Antidepressant Actions of Brain-Derived Neurotrophic Factor Require Vascular Endothelial Growth Factor.
Deyama S; Bang E; Kato T; Li XY; Duman RS
Biol Psychiatry; 2019 Jul; 86(2):143-152. PubMed ID: 30712809
[TBL] [Abstract][Full Text] [Related]
2. Role of Neuronal VEGF Signaling in the Prefrontal Cortex in the Rapid Antidepressant Effects of Ketamine.
Deyama S; Bang E; Wohleb ES; Li XY; Kato T; Gerhard DM; Dutheil S; Dwyer JM; Taylor SR; Picciotto MR; Duman RS
Am J Psychiatry; 2019 May; 176(5):388-400. PubMed ID: 30606046
[TBL] [Abstract][Full Text] [Related]
3. IGF-1 release in the medial prefrontal cortex mediates the rapid and sustained antidepressant-like actions of ketamine.
Deyama S; Kondo M; Shimada S; Kaneda K
Transl Psychiatry; 2022 May; 12(1):178. PubMed ID: 35577782
[TBL] [Abstract][Full Text] [Related]
4. Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine.
Ghosal S; Bang E; Yue W; Hare BD; Lepack AE; Girgenti MJ; Duman RS
Biol Psychiatry; 2018 Jan; 83(1):29-37. PubMed ID: 28751069
[TBL] [Abstract][Full Text] [Related]
5. Intranasal Administration of Resolvin E1 Produces Antidepressant-Like Effects via BDNF/VEGF-mTORC1 Signaling in the Medial Prefrontal Cortex.
Deyama S; Aoki S; Sugie R; Fukuda H; Shuto S; Minami M; Kaneda K
Neurotherapeutics; 2023 Mar; 20(2):484-501. PubMed ID: 36622634
[TBL] [Abstract][Full Text] [Related]
6. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2
Fukumoto K; Fogaça MV; Liu RJ; Duman C; Kato T; Li XY; Duman RS
Proc Natl Acad Sci U S A; 2019 Jan; 116(1):297-302. PubMed ID: 30559184
[TBL] [Abstract][Full Text] [Related]
7. The duration of the antidepressant-like effects of a single infusion of brain-derived neurotrophic factor into the medial prefrontal cortex in mice.
Deyama S; Kaneda K
Behav Brain Res; 2020 Sep; 394():112844. PubMed ID: 32745661
[TBL] [Abstract][Full Text] [Related]
8. Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine.
Deyama S; Duman RS
Pharmacol Biochem Behav; 2020 Jan; 188():172837. PubMed ID: 31830487
[TBL] [Abstract][Full Text] [Related]
9. BDNF release and signaling are required for the antidepressant actions of GLYX-13.
Kato T; Fogaça MV; Deyama S; Li XY; Fukumoto K; Duman RS
Mol Psychiatry; 2018 Oct; 23(10):2007-2017. PubMed ID: 29203848
[TBL] [Abstract][Full Text] [Related]
10. BDNF release is required for the behavioral actions of ketamine.
Lepack AE; Fuchikami M; Dwyer JM; Banasr M; Duman RS
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539510
[TBL] [Abstract][Full Text] [Related]
11. Role of neurotrophic and growth factors in the rapid and sustained antidepressant actions of ketamine.
Deyama S; Kaneda K
Neuropharmacology; 2023 Feb; 224():109335. PubMed ID: 36403852
[TBL] [Abstract][Full Text] [Related]
12. Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT
Fukumoto K; Fogaça MV; Liu RJ; Duman CH; Li XY; Chaki S; Duman RS
Neuropsychopharmacology; 2020 Sep; 45(10):1725-1734. PubMed ID: 32396921
[TBL] [Abstract][Full Text] [Related]
13. [Elucidation of the Mechanisms Underlying the Rapid Antidepressant Actions of Ketamine and Search for Possible Candidates for Novel Rapid-acting Antidepressants].
Deyama S
Yakugaku Zasshi; 2023; 143(9):713-720. PubMed ID: 37661437
[TBL] [Abstract][Full Text] [Related]
14. Role of BDNF in the pathophysiology and treatment of depression: Activity-dependent effects distinguish rapid-acting antidepressants.
Duman RS; Deyama S; Fogaça MV
Eur J Neurosci; 2021 Jan; 53(1):126-139. PubMed ID: 31811669
[TBL] [Abstract][Full Text] [Related]
15. Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures.
Lepack AE; Bang E; Lee B; Dwyer JM; Duman RS
Neuropharmacology; 2016 Dec; 111():242-252. PubMed ID: 27634096
[TBL] [Abstract][Full Text] [Related]
16. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects.
Saarelainen T; Hendolin P; Lucas G; Koponen E; Sairanen M; MacDonald E; Agerman K; Haapasalo A; Nawa H; Aloyz R; Ernfors P; Castrén E
J Neurosci; 2003 Jan; 23(1):349-57. PubMed ID: 12514234
[TBL] [Abstract][Full Text] [Related]
17. Sestrin modulator NV-5138 produces rapid antidepressant effects via direct mTORC1 activation.
Kato T; Pothula S; Liu RJ; Duman CH; Terwilliger R; Vlasuk GP; Saiah E; Hahm S; Duman RS
J Clin Invest; 2019 Apr; 129(6):2542-2554. PubMed ID: 30990795
[TBL] [Abstract][Full Text] [Related]
18. Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine.
Yao W; Cao Q; Luo S; He L; Yang C; Chen J; Qi Q; Hashimoto K; Zhang JC
Mol Psychiatry; 2022 Mar; 27(3):1618-1629. PubMed ID: 34819637
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex.
Sales AJ; Fogaça MV; Sartim AG; Pereira VS; Wegener G; Guimarães FS; Joca SRL
Mol Neurobiol; 2019 Feb; 56(2):1070-1081. PubMed ID: 29869197
[TBL] [Abstract][Full Text] [Related]
20. BDNF - a key transducer of antidepressant effects.
Björkholm C; Monteggia LM
Neuropharmacology; 2016 Mar; 102():72-9. PubMed ID: 26519901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
